IPSC
Century Therapeutics, Inc. · Healthcare · Market cap $351.3M
Insiders sold $12K net in the last 90 days ·2 sellers, 0 buyers· latest Form 4 filed Sep 9, 2026
Insider Buying
$97K
reported purchases (SEC code P)
Insider Selling
$78K
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Sep 9, 2026
Russotti Gregory
Century Therapeutics, Inc. (IPSC) has 39 SEC Form 4 filings (39 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Sep 9, 2026.
Inside the rolling window, 4 insiders at Century Therapeutics, Inc. reported 3 open-market purchases totaling $97K and 18 open-market sales totaling $78K. The most active filer is SVP Finance & Operations Carr Douglas with 10 filings. The most recent open-market filing is a sale of 534 shares by See Remarks Russotti Gregory, dated Sep 8, 2026, worth $1K.
- Industry:Biotechnology
- CEO:Brent Pfeiffenberger
- Employees:78
- HQ:Philadelphia, PA, US
- IPO:2021-06-18
| Source | |||||||
|---|---|---|---|---|---|---|---|
| See Remarks | Sale | 534 | $1K | Sep 9 | -4.4% | SEC ↗ | |
| SVP Finance & Operations | Sale | 254 | $521 | Sep 9 | -4.4% | SEC ↗ | |
| SVP Finance & Operations | Sale | 275 | $544 | Aug 5 | -1.0% | SEC ↗ | |
| See Remarks | Sale | 2,584 | $6K | Jun 15 | -15.7% | SEC ↗ | |
| SVP Finance & Operations | Sale | 1,654 | $4K | Jun 15 | -15.7% | SEC ↗ | |
| See Remarks | Sale | 524 | $1K | Jun 9 | -12.2% | SEC ↗ | |
| SVP Finance & Operations | Sale | 249 | $526 | Jun 9 | -12.2% | SEC ↗ | |
| SVP Finance & Operations | Sale | 264 | $618 | May 6 | -17.1% | SEC ↗ | |
| SVP Finance & Operations | Sale | 7,043 | $18K | Mar 16 | -20.2% | SEC ↗ | |
| See Remarks | Sale | 10,076 | $26K | Mar 16 | -20.2% | SEC ↗ | |
Russotti GregoryFirst in 3 months | See Remarks | Sale | 479 | $1K | Mar 11 | — | SEC ↗ |
| SVP Finance & Operations | Sale | 247 | $626 | Mar 11 | — | SEC ↗ | |
| SVP Finance & Operations | Sale | 323 | $589 | Feb 5 | — | SEC ↗ | |
| Chief Scientific Officer | Purchase | 58,060 | $49K | Dec 29 | — | SEC ↗ | |
| President and CEO | Purchase | 52,000 | $30K | Dec 16 | — | SEC ↗ | |
Russotti GregoryFirst filing | See Remarks | Sale | 526 | $280 | Dec 10 | — | SEC ↗ |
| SVP Finance & Operations | Sale | 257 | $137 | Dec 10 | — | SEC ↗ | |
Cowan ChadFirst filing | Chief Scientific Officer | Sale | 5,462 | $3K | Nov 24 | — | SEC ↗ |
| President and CEO | Purchase | 35,000 | $17K | Nov 20 | — | SEC ↗ | |
Pfeiffenberger BrentFirst filing | President and CEO | Sale | 32,456 | $15K | Nov 19 | — | SEC ↗ |
Carr DouglasFirst filing | SVP Finance & Operations | Sale | 292 | $171 | Nov 5 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does IPSC have?
Century Therapeutics, Inc. (IPSC) has 39 SEC Form 4 filings (39 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Sep 9, 2026.
When was the most recent SEC Form 4 filing for IPSC?
The most recent Form 4 filing for IPSC on Tracefour is dated Sep 9, 2026.
Who is the most active insider at IPSC?
The most active SEC Form 4 filer at IPSC in the rolling window is SVP Finance & Operations Carr Douglas, with 10 filings.
What is the net insider flow at IPSC over the last 6 months?
Over the trailing 180 days, insiders at IPSC have net sold $58K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at IPSC in the current window?
Inside the rolling window, insiders at IPSC bought $97K and sold $78K based on SEC Form 4 filings.
Can I get alerts for IPSC insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Century Therapeutics, Inc. (IPSC). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Century Therapeutics, Inc. is in the Healthcare sector.